Andrea Herman, RN, BA
Manager of Clinical Trials
Andrea is Manager of Clinical Trials for HepQuant, LLC. In this role she is responsible for managing clinical sites and sponsors. Andrea provides overall Project Management in addition to the HepQuant test training and project implementation at clinical sites. She provides essential QA functions throughout the company and in support of the Regulatory Director.
Prior to joining HepQuant in February 2017, Andrea served as Project Manager at ClinicalRM, a contract research organization (CRO) based in Ohio that supports federal and commercial sponsors to develop vaccines, drugs, diagnostics, and medical devices. In this role, Andrea developed and remotely managed internal and external teams supporting Phase 1 and 2 clinical research studies. She also held the role of In-country Site and Project Manager in Liberia.
From 2005 to 2015, Andrea was Senior Clinical Research Coordinator at the University of Colorado-Denver Anschutz Medical Campus where she coordinated multiple clinical studies focused on Hepatitis C and pre- and post-liver transplants, sponsored by pharmaceutical companies and National Institute of Health (NIH). In this position, Andrea was actively involved in the development of the HepQuant liver function tests with inventor Dr. Greg Everson.
Andrea has also served as Clinical Nurse at the University of Colorado Hospital, General Clinical Research Center where she implemented multiple study protocols on the inpatient and outpatient units.
Among others, her publications and posters include contributions to “Early Improvements in HepQuant SHUNT Function Test during Treatment with Ledipasvir/Sofosbuvir in Liver Transplant Recipients with Allograft Fibrosis or Cirrhosis and Patients with Decompensated Cirrhosis who have not Undergone Transplantation.”
Accredited as a Registered Nurse through the Colorado State Board of Nursing, Andrea earned a B.A. in Psychology from Rutgers University Douglas College in New Jersey, and AA Letters, Arts and Sciences from Penn State.